Dr Ross Upton is Chief Executive Officer and co-founder of Ultromics, a health-technology company, which leverages AI to automate echocardiogram analysis, including the first world’s first heart disease prediction tool. Ultromics supports physicians with the detection and diagnosis of cardiovascular disease - the leading cause of death globally.
Ross’ vision for Ultromics took shape during his DPhil, at the University of Oxford, whilst also training as a cardiac sonographer in the UK’s NHS. He holds a DPhil in Cardiovascular Medicine at the University of Oxford, an MSc in Clinical Cardiovascular Science (Newcastle), and an MSc in Clinical Biochemistry (University of Surrey).
While there are encouraging signs of reimbursement falling in step with the move towards a more value-based healthcare system, what is needed now to further encourage healthcare innovators is to properly rationalize approval processes imposed by the FDA and CMS.